Sheaff Brock Investment Advisors LLC Has $621,000 Holdings in Zoetis Inc. (NYSE:ZTS)

Sheaff Brock Investment Advisors LLC cut its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 2.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,180 shares of the company’s stock after selling 95 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Zoetis were worth $621,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. M&G Plc purchased a new stake in shares of Zoetis during the 1st quarter worth about $19,819,000. Cetera Investment Advisers raised its stake in shares of Zoetis by 275.2% during the 1st quarter. Cetera Investment Advisers now owns 96,085 shares of the company’s stock worth $16,259,000 after purchasing an additional 70,476 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Zoetis by 49.6% during the 1st quarter. Acadian Asset Management LLC now owns 25,051 shares of the company’s stock worth $4,235,000 after purchasing an additional 8,302 shares in the last quarter. Soltis Investment Advisors LLC purchased a new stake in shares of Zoetis during the 1st quarter worth about $688,000. Finally, Bank Pictet & Cie Asia Ltd. raised its stake in shares of Zoetis by 41.0% during the 2nd quarter. Bank Pictet & Cie Asia Ltd. now owns 37,500 shares of the company’s stock worth $6,501,000 after purchasing an additional 10,900 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently weighed in on ZTS. Argus raised Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. BTIG Research raised their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus raised their price objective on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. JPMorgan Chase & Co. raised their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Piper Sandler raised their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $221.44.

Zoetis Trading Up 0.3 %

Shares of ZTS opened at $175.12 on Friday. The stock has a fifty day moving average price of $187.09 and a two-hundred day moving average price of $180.08. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The company has a market cap of $79.01 billion, a price-to-earnings ratio of 32.92, a PEG ratio of 2.68 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. During the same quarter in the previous year, the company posted $1.36 EPS. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. Analysts predict that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be given a dividend of $0.432 per share. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.99%. Zoetis’s payout ratio is currently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.